Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 321, Issue 1, pp 52–55 | Cite as

Facilitation of stimulation-evoked catecholamine release by somatostatin in dog perfused adrenal glands

  • A. Tsujimoto
  • K. Morita
Article

Summary

The effect of somatostatin on the catecholamine (CA) release from the chromaffin cells was determined on the isolated dog adrenals perfused with 1.8 mM Ca2+ containing fluid except indicated. The extremely low concentrations of somatostatin (0.18 nM – 18 nM) were found to stimulate acetylcholine (ACh, 5 μM)-evoked CA release with the maximum response (by 114% above control) at 1.8 nM but the relatively high concentrations (61, 610 nM) caused an inhibition. Somatostatin (6.1 nM) also facilitated excess K+ (15 mM)-induced CA release but failed to enhance the release evoked by a Ca2+ ionophore, A23187 (50 μM) and the release by caffeine (50 mM) under the condition of Ca2+-free. Somatostatin by itself did not affect significantly on the basal release of CA. Elevation of Ca2+ concentrations from 1.8 mM to 5 mM in the perfusion fluid reduced the stimulatory and inhibitory effect of somatostatin. It is possible that somatostatin enhances CA release by facilitating the influx of Ca2+ via the potential-sensitive permeability channel when chromaffin cells are depolarized. The present results provide the first demonstration that somatostatin stimulate the release of CA from the adrenal gland suggesting that somatostatin may function as a facilitatory modulator of the response to ACh at chromaffin cells.

Key words

Somatostatin (somatotropin release inhibiting hormone) Catecholamine release Adrenal glands 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alberti KGMM, Christensen SE, Iversen J, Seyer-Hansen K, Christensen NJ, Prange-Hansen A, Lundbaek K, Ørskov H (1973) Inhibition of insulin secretion by somatostatin. Lancet II 1299–1301Google Scholar
  2. Barker JL (1977) Physiological roles of peptides in the nervous system. In: Gainer H (eds) Peptides in neurology. Plenum Press, New York, pp 295–343Google Scholar
  3. Bloom SR, Mortimer CH, Thorner MO, Besser GM, Hall R, Gomez-Pan A, Roy VM, Russell RCG, Coy DH, Kastin AJ, Schally AV (1974) Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone. Lancet II 1106–1109Google Scholar
  4. Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rivier J, Guillemin R (1973) Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179:77–79Google Scholar
  5. Cochrane DE, Douglas WW, Mouri T, Nakazato Y (1975) Calcium and stimulus-secretion coupling in the adrenal medulla: contrasting stimulating effects of the ionophores X-537A and A23187 on catecholamine output. J Physiol (Lond) 252:363–378Google Scholar
  6. Cotman CW, Haycock JW, White FW (1976) Stimulus-secretion coupling processes in brain: analysis of noradrenaline and gammaaminobutyric acid release. J Physiol (Lond) 254:475–505Google Scholar
  7. Douglas WW (1968) Stimulus-secretion coupling: the concept and clues from chromaffin and other cells. Br J Pharmacol 34:451–474Google Scholar
  8. Douglas WW, Rubin RP (1963) The mechanism of catecholamine release from the adrenal medulla and the role of calcium in stimulus-secretion coupling. J Physiol (Lond) 167:288–310Google Scholar
  9. Epelbaum J, Brazeau P, Tsang D, Brawer J, Martin JB (1977) Subcellular distribution of radioimmunoassayable somatostatin in rat brain. Brain Res 126:309–323Google Scholar
  10. Euler US v, Floding I (1955a) Fluorimetric estimation of noradrenaline and adrenaline in urine. Acta Physiol Scand 33 Suppl 118:57–62Google Scholar
  11. Euler US v, Floding I (1955b) A fluorimetric micromethod for differential estimation of adrenaline and noradrenaline. Acta Physiol Scand 33 Suppl 118:45–56Google Scholar
  12. Euler US v, Lishajko F (1961) Improved technique for the fluorometric estimation of catecholamines. Acta Physiol Scand 51:348–356Google Scholar
  13. Göthert M (1980) Somatostatin selectively inhibits noradrenaline release from hypothalamic neurones. Nature 288:86–88Google Scholar
  14. Hökfelt T, Elfvin LG, Elde R, Schultzberg M, Goldstein M, Luft R (1977) Occurrence of somatostatin immunoreactivity in some peripheral sympathetic noradrenergic neurons. Proc Natl Acad Sci USA 74:3587–3591Google Scholar
  15. Ito S, Nakazato Y, Ohga A (1978) The effect of the ionophores X-537A and A23187 on the noradrenaline output from peripheral adrenergic neurones in the presence of various divalent cations. Br J Pharmacol 62:91–98Google Scholar
  16. Iversen LL, Iversen SD, Bloom FE, Douglas C, Brown M, Vale W (1978) Calcium-dependent release of somatostatin and neurotensin in vitro. Nature 273:161–163Google Scholar
  17. Luft R, Effendić S, Hökfelt T (1978) Somatostatin — both hormone and neurotransmitter. Diabetologia 14:1–13Google Scholar
  18. Lundberg JM, Hamberger B, Schultzberg M, Hökfelt T, Granberg PO, Effendić S, Terenius L, Goldstein M, Luft R (1979) Enkephalin- and somatostatin-like immunoreactivities in human medulla and pheochromocytoma. Proc Natl Acad Sci USA 76:4079–4083Google Scholar
  19. Mizobe F, Kozousek V, Dean DM, Livett BG (1979) Pharmacological characterization of adrenal paraneurons: substance P and somatostatin as inhibitory modulators of the nicotinic response. Brain Res 178:555–566Google Scholar
  20. Pfeiffer DR, Taylor RW, Lardy HA (1978) Ionophore A23187: Cation binding and transport properties. Ann NY Acad Sci 307:402–421Google Scholar
  21. Poisner AM (1973) Caffeine-induced catecholamine secretion: Similarity to caffeine-induced muscle contraction. Proc Soc Exp Biol Med 142:103–105Google Scholar
  22. Quirion R, Regoli D, Rioux F, St-Pierre S (1979) An analysis of the negative inotropic action of somatostatin. Br J Pharmacol 66:251–257Google Scholar
  23. Rahwan RG, Borowitz JL, Miya TS (1973) The role of intracellular calcium in catecholamine secretion from the bovin adrenal medulla. J Pharmacol Exp Ther 184:106–118Google Scholar
  24. Rasmussen H, Goodman DBP (1977) Relationship between calcium and cyclic nucleotides in cell activation. Physiol Rev 57:421–509Google Scholar
  25. Renaud LP, Martin JB, Brazeau P (1975) Depressant action of TRH, LH-RH and somatostatin on activity of central neurones. Nature 255:233–235Google Scholar
  26. Richardson UI, Schonbrunn A (1981) Inhibition of adrenocorticotropin secretion by somatostatin in pituitary cells in culture. Endocrinology 108:281–290Google Scholar
  27. Robinson RL (1966) Stimulation of the release of catecholamines from isolated adrenal glands by tyramine. J Pharmacol Exp Ther 151:55–58Google Scholar
  28. Rosenberger L, Triggle DJ (1978) Calcium, calcium translocation, and specific calcium antagonist. In: Weiss GB (ed) Calcium in drug action. Plenum Press, New York, pp 3–31Google Scholar
  29. Tanaka S, Tsujimoto A (1981) Somatostatin facilitates the serotonin release from rat cerebral cortex, hippocampus and hypothalamus slices. Brain Res 208:219–222Google Scholar
  30. Thoa NB, Costa JL, Moss J, Kopin IJ (1974) Mechanism of release of norepinephrine from peripheral adrenergic neurons by the calcium ionophore X537A and A23187. Life Sci 14:1705–1719Google Scholar
  31. Tsujimoto A, Tanaka S (1981) Stimulatory effect of somatostatin on norepinephrine release from rat brain cortex slices. Life Sci 28:903–910Google Scholar
  32. Tsujimoto A, Morita K, Nishikawa T, Yamada S (1980) Cyclic nucleotide elevation proceeding catecholamine release in isolated dog adrenals. Arch Int Pharmacodyn Ther 245:262–270Google Scholar
  33. Vale W, Rivier C, Brazeau P, Guillemin R (1974) Effects of somatostatin on the secretion of thyrotropin and prolactin. Endocrinology 95:968–977Google Scholar
  34. Vale W, Rivier C, Brown M (1980) Physiology and pharmacology of hypothalamic regulatory peptides. In: Morgane PJ, Panksepp J (eds) Handbook of the hypothalamus, vol 2, Physiology of the hypothalamus. Marcel Dekker, New York, pp 165–252Google Scholar

Copyright information

© Springer-Verlag 1982

Authors and Affiliations

  • A. Tsujimoto
    • 1
  • K. Morita
    • 1
  1. 1.Department of PharmacologyHiroshima University, School of DentistryHiroshimaJapan

Personalised recommendations